Finance
Genetics-based company reports third quarter 2004 financial results
Published in AIDS Weekly, November 29th, 2004
Revenue for the third quarter of 2004 was $2.4 million compared to $5.0 million for the third quarter of 2003. Revenue for the 9 months ended September 30, 2004 decreased to $6.5 million from $12.7 million for the same period of 2003.
Revenues in 2004 reflect amounts earned under the company's AIDS vaccine collaboration with the International AIDS Vaccine Initiative (IAVI) and the Columbus Children's Research Institute, which increased in 2004 compared to 2003, and to a lesser degree contract manufacturing revenue earned in the first quarter of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-11-29)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Rapid field test sensitive and specific for detecting/differentiating HIV types - HIV/AIDS Research
High-throughput assay identifies CCR5/CD4-mediated HIV virus entry inhibitors - HIV/AIDS Therapy
Protease inhibitor fosamprenavir potent against advanced HIV disease - HIV/AIDS-Related Transmission
HIV viral load increases in breast milk following ZDV discontinuation - AIDS/HIV Transmission
Model of perinatal transmission of SHIV in macaques developed - AIDS/HIV Vaccine
HIV-1 Tat protein modulates generation of cytotoxic T cell epitopes - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
